AVI-4020

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAVI-4020
Drug Alias NameAVI-4020
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsWest Nile Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarepta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsWest Nile Fever

Other Information

ATC CodeN/A
Related LinksN/A